Related Experiment Video
Updated: Aug 10, 2026

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
Published on: April 2, 2013
Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line
1Case Western Reserve School of Medicine, Cleveland, Ohio.
Abstract:
Cryptosporidium parvum is a protozoan parasite that causes severe enteritis in patients with AIDS for which there is no effective therapy. Paromomycin is a nonabsorbable aminoglycoside that is effective in the treatment of other intestinal protozoa. The ability of paromomycin to inhibit C. parvum infection of a differentiated human enterocyte cell line was evaluated in vitro. Paromomycin concentrations ranging from 50 to 5000 micrograms/ml inhibited infection at 24 h in a dose-dependent fashion. Concentrations greater than 1000 micrograms/ml, which are theoretically achievable in the bowel lumen, inhibited infection by greater than 85% (P less than .001). Prospective clinical trials of paromomycin for the treatment of cryptosporidiosis in patients with AIDS are warranted.
Insights
Paromomycin shows promise for treating Cryptosporidium parvum infections in AIDS patients. This nonabsorbable aminoglycoside significantly inhibited parasite infection in human enterocyte cell lines in vitro.
Area of Science:
- Medical Parasitology
- Infectious Diseases
- Gastroenterology
Background:
- Cryptosporidium parvum causes severe enteritis in AIDS patients, lacking effective treatments.
- Paromomycin is an aminoglycoside effective against other intestinal protozoa.
Purpose of the Study:
- To evaluate the in vitro efficacy of paromomycin against Cryptosporidium parvum infection.
Main Methods:
- Assessed paromomycin's inhibition of C. parvum in a human enterocyte cell line.
- Tested concentrations ranging from 50 to 5000 µg/ml over 24 hours.
Main Results:
- Paromomycin demonstrated dose-dependent inhibition of C. parvum infection.
- Concentrations >1000 µg/ml achieved >85% inhibition (P < .001).
Conclusions:
- Paromomycin effectively inhibits C. parvum in vitro.
- Clinical trials of paromomycin for AIDS-associated cryptosporidiosis are recommended.
Related Concept Videos
Fungal Phylum Microsporidia
Diversity of Protists II

